Search results
Pfizer Inc. (NYSE:PFE) Shares Sold by Cresset Asset Management LLC
ETF DAILY NEWS· 5 days agoCresset Asset Management LLC reduced its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent disclosure ...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters via AOL· 5 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...
Pfizer faces setback with gene therapy acquired from North Carolina firm - Triangle Business Journal
The Business Journals· 4 days agoPfizer is facing a major clinical setback in a gene therapy program with ties to the Triangle. The...
Fact Check: Joel Osteen Rumor Claims He's Leaving Ministry After Event Organizers Kicked Him Out of...
Snopes· 4 days agoOn June 12, 2024, Snopes looked into a rumor claiming Joel Osteen — the leader of the Houston, Texas...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 5 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 5 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 4 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
Pfizer's DMD gene therapy falls short in phase 3 trial
Becker’s Hospital Review· 4 days agoPfizer's gene therapy candidate for Duchenne muscular dystrophy failed to meet its primary endpoint in a phase 3 trial, the company said June 12. The study tested the experimental ...
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
InvestorPlace via Yahoo Finance· 6 days agoOn Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part...
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open
Barrons.com· 4 days agoThe drug company Pfizer said a gene therapy it is testing failed to improve motor function in boys...
